ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,540 | +289.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $652 | +65100.0% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1 | -100.0% | 2,000 | -33.3% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | -33.3% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -66.7% | 3,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $9,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $9,000 | -30.8% | 3,000 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $13,000 | -27.8% | 3,000 | +50.0% | 0.01% | -30.8% |
| Q4 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.01% | -31.6% |
| Q1 2020 | $18,000 | +200.0% | 2,000 | +100.0% | 0.02% | +280.0% |
| Q4 2019 | $6,000 | -25.0% | 1,000 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $8,000 | -42.9% | 1,000 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $14,000 | +180.0% | 1,000 | 0.0% | 0.01% | +140.0% |
| Q1 2019 | $5,000 | +66.7% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $3,000 | -62.5% | 1,000 | 0.0% | 0.00% | -57.1% |
| Q3 2018 | $8,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |